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The object of treatment is to pre-
vent and/or limit absorption of the
poisonous substance and to main-
tain vital functions, such as ventila-
tion and circulation. Once life
support measures have been
addressed, attention should be
given to other aspects such as iden-
tification of the poison, specific
treatment and enhancement of
elimination. In the management
strategy, distinction should be
drawn between exposure to poiso-
nous substances and true poison-
ings, since the one does not neces-
sarily lead to the other.1-5
TERMINATING EXPOSURE
Skin
Absorption of toxins through the
skin and corrosive damage to the
tissues at the point of contact
should be limited by immediately
removing contaminated clothing,
and washing with copious quanti-
ties of soap and water. The corro-
sive effects of hydrofluoric acid can
effectively be terminated by apply-
ing a 10% calcium gluconate solu-
tion to the affected areas.
Eyes
Corrosive alkalis and acids, and
other irritants, should be removed
from the eyes by continuous irriga-
tion with tap water or 0.9% saline
for 30 minutes. In all but minor
incidents the patient should be
referred to an ophthalmologist for
specialist advice.
Emesis
Stimulation of the pharynx to
induce emesis is safe provided that
the patient is fully conscious and
no contraindications (see else-
where) to the procedure exist.
Induction of emesis in this way is
not always effective but efficacy
may be improved by giving the
patient a glass of tepid water to
drink before the attempt. Saline
emetics should not be used, since
they may cause hypernatraemia.
Ipecacuanha
The use of ipecacuanha is discour-
aged, since there is no evidence in
the literature to indicate that the
potential benefits of its use out-
weigh the risks. Furthermore,
ipecacuanha may cause persistent
vomiting, diarrhoea, lethargy and
drowsiness, effects which may
complicate making an accurate
diagnosis.
Gastric lavage
Lavage should not be used routine-
ly in the management of oral expo-
sure to poisonous substances.
There is no evidence that its use
improves outcome, and it may even
cause significant morbidity.
Unfortunately, this procedure is
often used as a means of  ‘punish-
ment’ of a patient who has taken
an overdose. There is no convinc-
ing clinical evidence that lavage,
later than 1 hour after ingestion of
a poisonous substance, is of thera-
peutic value.
Lavage should only be considered
within 1 - 2 hours after ingestion
where a patient has taken a large
amount of a poison with high
inherent toxicity. Lavage can in
fact enhance the absorption of a
poisonous substance; the large vol-
umes of water increase dissolution
of the toxic compound and may
even flush it into the duodenum.
A large-bore orogastric tube/hose,
32 - 40F in adults, and 16 - 28F in
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Management of acute poisoning
Acute poisoning requires prompt supportive treatment to
ensure the best outcome. Once this is achieved, the poison









the one does not
necessarily lead to
the other.
children, should be used if solid
material, such as tablets, capsules,
etc. has been ingested (Fig. 1). In
patients at risk of aspiration (e.g.
patients with CNS depression or
predisposed to seizures) airway
protection is essential before gas-
tric emptying is attempted.6
Activated charcoal
Charcoal (see also the article on
antidotes, p. 452) adsorbs (binds)
poisons, thereby limiting their
absorption. The greatest benefit is
achieved if the charcoal is adminis-
tered within 2 hours of ingestion of
a poisonous substance. Activated
charcoal is inert and generally safe
and easy to use. Large doses may
occasionally cause constipation.
The usual single stat dose is 1 - 1.5
g/kg (50 - 100 g for an adult and
15 - 30 g for a child) given as an
aqueous slurry, with 250 - 500 ml
of water, i.e. 1 glass of water for
every 30 - 50 g of charcoal.
Activated charcoal is contraindicat-
ed after ingestion of a corrosive
substance or when immediate
endoscopy is to be undertaken.
Water-soluble substances are not
effectively adsorbed by activated
charcoal. These include acids and
alkalis, alcohols (including ethylene
glycol and methanol), heavy metals
(such as iron), arsenic, lithium and
potassium salts. Contrary to what
would be expected, charcoal does
not effectively bind paraffin and
related substances.6
Cathartics
The use of cathartics (e.g. sor-
bitol), with or without activated
charcoal, is not recommended for
gastrointestinal decontamination





Apart from specific measures
directed at the poison itself (eme-
sis, charcoal, antidotes, etc.), care-
ful ongoing observation and fre-
quent re-evaluation of the patient
form the cornerstones of manage-
ment and care. Appropriate sup-
portive care and effective relief of
symptoms should not be neglected.
Emergency procedures should be
directed at maintaining a patent
airway, providing respiratory sup-
port, and effecting cardiovascular
resuscitation if and when neces-
sary. The loss of an effective air-
way and inadequate ventilation are
the most common causes of seri-
ous morbidity and death in poison-
ing.4
In comatose patients reliable
venous access should be estab-
lished and urine flow should be
monitored.
Hypoventilation
Inadequate ventilation should be
prevented by ensuring an adequate
airway with immediate access to
suction equipment, oxygen, and
mechanical ventilation. Most poi-
sons that depress consciousness
also impair respiration. An
obstructed airway needs immediate
attention: dentures and oral secre-
tions should be removed, an oral
airway tube should be inserted,
and the jaw should be extended
forwards with the patient turned
onto the left side (left lateral posi-
tion).3
Hypoglycaemia
Adequate blood glucose levels
should be ensured in the comatose
patient. If hypoglycaemia is pre-
sent, 50 ml of 50% dextrose solu-
tion should be administered intra-
venously (adult dose). Hypogly-
caemia should be suspected in poi-
soning/overdose with oral hypogly-
caemics, salicylates and ethanol.
Dextrose solution (50%) should
not be administered before low
blood glucose levels have been
confirmed by a bedside finger
prick blood glucose test. The
empiric administration of high glu-
cose concentrations should be
avoided in patients at risk of cen-
tral ischaemia, e.g. patients with
raised intracranial pressure, poor
cerebral perfusion, cardiac output
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Fig. 1. The larger tube is the minimum
diameter required for effective gastric
lavage in adults (32F). The stomach
tube held (minimum size required for
children) is the size (16F) routinely
used for adults in most South African
hospitals. It is clear that much larger
tubes should be used for the effective







hypotension, and in patients receiv-
ing CPR.7
Volume depletion
Loss of fluid secondary to vomit-
ing, diarrhoea and sweating is
common and losses should be cor-
rected. It is a common complica-
tion of severe, cytotoxic snake bite
(puff adder bite), which may be
quite pronounced in children.
Hypotension
Hypotension occurs most com-
monly after severe barbiturate poi-
soning. Irrespective of the cause,
e.g. volume depletion or venous
pooling, central venous pressure
monitoring should be resorted to
for accurate assessment of fluid
requirements.
Cardiac conduction and rhythm
defects
Dysrhythmias and conduction
defects may occur in acute poison-
ing with various substances. ECG
monitoring is advisable and atten-
tion should be given to aggravating
factors such as acidosis, hypoxia
and electrolyte/fluid disturbances.
Treatment will depend on the
toxin involved and the type of dys-
rhythmia.
Seizures
Seizures that are self limiting and
of short duration do not require
immediate anticonvulsive therapy.
Intravenous diazepam should be
administered if convulsions are
protracted or recur. Phenytoin is
an effective alternative agent. For
the treatment of status epilepticus
which is unresponsive to the usual
measures, thiopentone and muscle
relaxants may be indicated (with
appropriate respiratory support).
Hypothermia
Hypothermia (< 35°C) may devel-
op in comatose patients and may
be missed by the unwary clinician.
A low-reading rectal thermometer
should be used to record the tem-
perature whenever hypothermia is
suspected.
Specific treatment/antidotes
The management of poisoning
with specific substances is dis-
cussed in greater detail in the arti-
cle  ‘Antidotes, supportive agents
and other essentials in the manage-
ment of acute toxic exposures and





The elimination of poisons (drugs)
with a small volume of distribution
(< 1 l/kg), low pKa (which max-
imises transport across mem-
branes), low binding affinity and
prolonged elimination half-life fol-
lowing overdose, is particularly
likely to be enhanced by MDAC.
This form of treatment should be
considered if a patient has ingested
a life-threatening quantity of carba-
mazepine, dapsone, phenobarbi-
tone, quinine or theophylline.
MDAC may also increase the elim-
ination of amitriptyline, dextro-
propoxyphene, digoxin, phenytoin,
nadolol and sotalol. Follow-up
doses of at least 12.5 g (less in
children) of activated charcoal
should be administered every hour.
The concurrent use of a cathartic
is not recommended for reasons
discussed above.
Alkaline diuresis
Although alkaline diuresis increases
the elimination of salicylates, phen-
oxyacetate herbicides, phenobarbi-
tone and barbitone, it is not always
possible to achieve the required
urinary pH of 8 and higher with
administration of the recommend-
ed 4.2% sodium bicarbonate solu-
tion. Furthermore, the procedure
should not be undertaken without
access to intensive care facilities
since frequent biochemical moni-
toring and appropriate responses to
results are required. Consequently,
this method of enhanced elimina-
tion is not generally resorted to.
Acetazolamide has been reported
to be an effective urinary alkalinis-
ing agent at a dose of 250 - 500
mg intravenously. However, aceta-
zolamide should not be used in the
management of salicylate poisoning
since it may exacerbate toxic
effects on the central nervous sys-
tem. Multiple-dose activated char-
coal is a safer and easier alternative
to alkaline diuresis.
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Multiple-dose
activated charcoal is
a safer and easier
alternative to alka-
line diuresis.
Activated charcoal is safe and easy to use.
Whole-bowel irrigation (WBI)  
This is achieved by oral adminis-
tration of large amounts of an iso-
osmotic polyethylene glycol (PEG)
electrolyte solution. This is better
known as Go-Lytely. The long-
chain PEGs are poorly absorbed
and retain water by virtue of their
high osmotic character; the
retained water stimulates peristal-
sis. WBI is not a procedure that is
used routinely but it is a treatment
option following the ingestion of
large amounts of iron tablets, or
sustained-release or enteric-coated
medicines with a high inherent tox-
icity. It has also been used for the
purpose of forcing the passage of
packages of illicit drugs through the
gut (e.g. cocaine in condoms, com-
monly known as ‘body packers’).
Dialysis and haemoperfusion
These procedures are of limited
value for the removal of toxins
which have a large volume of dis-
tribution (e.g. tricyclic antidepres-
sants). Haemodialysis enhances
the elimination of water-soluble
compounds, e.g. lithium,
methanol, isopropanol, ethylene
glycol and ethanol, and some lipid-
soluble compounds that (contrary
to expectation) have a small vol-
ume of distribution. Haemoper-
fusion through an activated char-
coal cartridge is highly effective in
reducing the concentration of
lipid-soluble compounds with a
small volume of distribution 




However, there is evidence that
multiple-dose activated charcoal is
as effective as haemoperfusion in
removing phenobarbitone, carba-
mazepine and theophylline from
the body in the poisoned patient.
Serotonin syndrome
Management includes monitoring
the urine for myoglobin (rhab-
domyolysis), reducing the tempera-
ture in hyperthermic patients, cor-
recting acid-base and electrolyte
imbalances and treating seizures
promptly with a benzodiazepine.
Cyproheptadine (4 - 8 mg orally)
has been used in the treatment of
serotonin syndrome. The dose
should be repeated in adults at 
1 - 4-hour intervals, until a thera-
peutic response is observed or a
maximum dose of 32 mg has been
administered. In children the rec-
ommended dose is 0.25 mg/kg/day,
divided into 6-hourly doses, to a
maximum of 12 mg/day.
Rhabdomyolysis
Initial treatment should be directed
towards controlling acute metabol-
ic and electrolyte disturbances,
hyperthermia, hypovolaemia,
seizures, restlessness, and muscle
contractions. The mainstay of
therapy is early and aggressive
administration of fluids. It is also
necessary to alkalinise the urine.
The urine pH should be kept at
≥ 7 and the serum bicarbonate
level at ≥ 20 mmol/l. Mannitol
and diuretics may be needed to
ensure adequate urine flow.
Haemodialysis should be consid-
ered if acute renal failure develops.
References available on request.
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IN A NUTSHELL
Continuous observation, re-
evaluation and supportive and
symptomatic treatment are the
cornerstones of the manage-
ment of the poisoned patient.
Emergency care begins with
maintaining the airway, sup-
porting respiration, and institut-
ing cardiovascular resuscita-
tion where necessary.
Loss of airway or inadequate
ventilation is the most com-
mon cause of serious morbidi-
ty or death in poisoning.
